SCHEMBL8098935

SCHEMBL8098935

CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1

nearest known ligand 0.90

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 17/20 0.90
EGFR P00533 12/20 0.90
ABL1 P00519 12/20 0.90
ABL2 P42684 11/20 0.90
LCK P06239 6/20 0.68
RET P07949 3/20 0.67
KIF5B P33176 3/20 0.67
IGF1R P08069 3/20 0.67
JAK2 O60674 2/20 0.67
NTRK1 P04629 2/20 0.67
INSR P06213 2/20 0.67
NPM1 P06748 2/20 0.67
CSF1R P07333 2/20 0.67
LYN P07948 2/20 0.67
MET P08581 2/20 0.67
PDGFRB P09619 2/20 0.67
KIT P10721 2/20 0.67
BCR P11274 2/20 0.67
FGFR1 P11362 2/20 0.67
PDGFRA P16234 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098846 0.91 SRC (0.75) SRCEGFRABL1ABL2LCK
SCHEMBL8098919 0.90 SRC (0.90) SRCEGFRABL1ABL2
SCHEMBL8108104 0.90 SRC (0.91) SRCEGFRABL1ABL2LCK
SCHEMBL8107053 0.89 SRC (0.90) SRCEGFRABL1ABL2RET
SCHEMBL7020683 0.88 SRC (0.74) SRCEGFRABL1ABL2LCK
SCHEMBL8112759 0.87 SRC (0.73) SRCEGFRABL1ABL2LCK
SCHEMBL28667953 0.87 SRC (0.79) SRCEGFRABL1ABL2
SCHEMBL8108111 0.85 SRC (1.00) SRCEGFRABL1ABL2LCK
SCHEMBL8107030 0.85 SRC (1.00) SRCEGFRABL1ABL2
SCHEMBL13020336 0.85 SRC (0.76) SRCEGFRABL1ABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed